Researchers at Washington University School of Medicine in St. Louis and elsewhere are investigating whether transfusions of blood plasma from people who have recovered from COVID-19 can prevent or treat the disease. The approach was used with some success during the 1918 influenza pandemic.
Among the research programs racing to develop therapies and vaccines for the new pandemic virus COVID-19 is one of the largest crowdsourced supercomputing projects in the world. Led by computational biophysicist Greg Bowman, at Washington University School of Medicine, the project is called Folding@home.
Scientists at Washington University School of Medicine have developed a new imaging agent that could let doctors identify tumors as well as the surrounding normal cells that act as a shield, protecting the tumor from various treatment strategies.
Washington University in St. Louis will begin construction in March on what will be one of the largest neuroscience research buildings in the country. Located on the School of Medicine campus, the 11-story, state-of-the-art research facility will merge, cultivate and advance some of the world’s leading neuroscience research.
Soon after a novel coronavirus first appeared, School of Medicine researchers, doctors and staff began preparing for a possible outbreak. Infectious disease physicians started planning how to respond, and researchers got to work finding drugs or vaccines for COVID-19.
A mouse study from Washington University School of Medicine in St. Louis suggests a type of immune cell may play a surprising role in the structure and rhythm of the heart.
The School of Medicine’s Healthy Work Center facilitates research to promote the health of working-age people by focusing on topics such as diet and exercise, cancer prevention and injury avoidance. It’s a rebooted version of the Occupational Safety and Health Research Lab.
Members of the School of Medicine lab of Matthew Ciorba, MD, have identified a way to make radiation therapy for colorectal cancer more effective by inhibiting a protein found in cancer cells in the gut.
A drug strategy aimed at revving up the immune system and boosting a type of immune cell known as natural killer cells appears, at least in mice, to effectively treat the skin condition eczema. A team led by the School of Medicine’s Brian S. Kim, MD, is behind the strategy.
Jeffrey R. Millman and his team at the Washington University School of Medicine produced human insulin-secreting beta cells from stem cells using a new efficient technique. The cells were able to rapidly cure diabetes in mice for at least nine months.
